Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Common Respiratory Disorders01:31

Common Respiratory Disorders

1.7K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.7K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

4.4K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.4K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

578
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
578
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.3K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing Pharmacoequity in Asthma.

JAMA·2026
Same author

AI Use in Research and the Need for Continued Guidance.

JAMA·2026
Same author

Fever, Rash, and Dizziness in a 32-Year-Old.

JAMA·2026
Same author

Driving after cannabis consumption among US adults ages 50 years and older: A short communication.

Drug and alcohol dependence·2025
Same author

Equity, Diversity, and Inclusion Concerns From JAMA Network Peer Reviewers.

JAMA network open·2025
Same author

Self-reported urinary tract infections in the past year among perimenopausal and postmenopausal women: a nationally representative survey.

Menopause (New York, N.Y.)·2025

Related Experiment Video

Updated: Mar 9, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.4K

Respiratory Syncytial Virus

Kathleen A Linder, Preeti N Malani

    JAMA
    |December 29, 2016
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    11.6K
    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
    09:01

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

    Published on: December 10, 2013

    8.4K

    Related Experiment Videos

    Last Updated: Mar 9, 2026

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
    11:48

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

    Published on: April 4, 2019

    17.4K
    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    11.6K
    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
    09:01

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

    Published on: December 10, 2013

    8.4K